XML 84 R70.htm IDEA: XBRL DOCUMENT
v3.20.2

Fair Value Considerations (Details 6) - Beta | Feb. 14, 2020 | Nov. 01, 2019
--- | --- | ---
Cerecor, Inc. | Product Technology Rights |  |  |
Re-levered Beta | [1] |  | 1.60
Market risk premium | [1] |  | 6.00%
Small stock risk premium | [1] |  | 5.20%
Risk-free interest rate | [1] |  | 2.00%
Company specific discount | [1] |  | 25.00%
Innovus Pharmaceuticals | Patents & Trademarks |  |  |
Re-levered Beta |  | 0.84 |
Market risk premium |  | 6.17% |
Small stock risk premium |  | 4.99% |
Risk-free interest rate |  | 1.89% |
Company specific discount |  | 20.00% |
[1] | Valuation performed as of November 1, 2019. As a non-recurring fair value measurement, there is no remeasurement at each reporting period unless indications exist that the fair value of the asset has been impaired. There were no indicators as of June 30, 2020 that the fair value of the Product technology rights was impaired.

X
- References No definition available. + Details
Name: | AYTU_CompanySpecificDiscount
Namespace Prefix: | AYTU_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | AYTU_MarketRiskPremium
Namespace Prefix: | AYTU_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | AYTU_ReleveredBeta
Namespace Prefix: | AYTU_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | AYTU_RiskFreeInterestRate
Namespace Prefix: | AYTU_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | AYTU_SmallStockRiskPremium
Namespace Prefix: | AYTU_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=AYTU_CerecorIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByAssetClassAxis=us-gaap_DevelopedTechnologyRightsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=AYTU_InnovusPharmaceuticalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByAssetClassAxis=us-gaap_TradeNamesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |